VRPX: Utang jangka cendhak perusahaan Virpax Pharmaceuticals Inc.

Virpax Pharmaceuticals (VRPX) utilizes an asset-light approach, licensing adapted molecules for nasal sprays to major players without constructing its own plants. The company develops innovative non-opioid treatments for CNS therapy and pain management, leveraging advanced delivery systems. The current metric stands at 0.00. This price trajectory for the securities on the GURU.Markets platform illustrates the price action of this biopharmaceutical developer.

For Virpax Pharmaceuticals (VRPX), which develops innovative non-opioid analgesic delivery systems, this indicator tracks the aggregate volume of liabilities with a maturity of up to one year. Analyzing current debt on loans and borrowings allows for an assessment of liquidity risks and the balance between financial stability and the efficiency of R&D investments, preventing capital losses in the intervals between quarterly reports.